THE RISKS AND COSTS OF UPPER GASTROINTESTINAL DISEASE ATTRIBUTABLE TO NSAIDS
- 1 June 1996
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 25 (2) , 373-396
- https://doi.org/10.1016/s0889-8553(05)70253-3
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1992
- Breast Augmentation: A Risk Factor for Breast Cancer?New England Journal of Medicine, 1992
- The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract diseaseArchives of internal medicine (1960), 1992
- Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugsArchives of internal medicine (1960), 1989
- Direct medical costs of disease and gastrointestinal side effects during treatment for arthritisThe American Journal of Medicine, 1988
- Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderlyArchives of internal medicine (1960), 1987
- BLOOD AND PROTEIN LOSS VIA SMALL-INTESTINAL INFLAMMATION INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGSThe Lancet, 1987
- The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugsArchives of internal medicine (1960), 1987
- The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleedingArchives of internal medicine (1960), 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985